The Role of Circulating Tumor Cells in the Prognosis of Metastatic Triple-Negative Breast Cancers: A Systematic Review of the Literature.

Autor: Lisencu LA; Department of Oncological Surgery and Gynecological Oncology, 'Iuliu Hațieganu' University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania., Trancă S; Department of Anaesthesia and Intensive Care II, 'Iuliu Hațieganu' University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania., Bonci EA; Department of Oncological Surgery and Gynecological Oncology, 'Iuliu Hațieganu' University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.; Department of Surgical Oncology, The Oncology Institute 'Prof. Dr. Ion Chiricuță', 400015 Cluj-Napoca, Romania., Pașca A; Department of Oncological Surgery and Gynecological Oncology, 'Iuliu Hațieganu' University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.; Department of Surgical Oncology, The Oncology Institute 'Prof. Dr. Ion Chiricuță', 400015 Cluj-Napoca, Romania., Mihu C; Department of Toxicology and Clinical Pharmacology, 'Iuliu Hatieganu' University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania., Irimie A; Department of Oncological Surgery and Gynecological Oncology, 'Iuliu Hațieganu' University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.; Department of Surgical Oncology, The Oncology Institute 'Prof. Dr. Ion Chiricuță', 400015 Cluj-Napoca, Romania., Tudoran O; Department of Genetics, Genomics and Experimental Pathology, The Oncology Institute 'Prof. Dr. Ion Chiricuță', 400015 Cluj-Napoca, Romania.; Department of Medical Oncology, 'Iuliu Hațieganu' University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania., Balacescu O; Department of Genetics, Genomics and Experimental Pathology, The Oncology Institute 'Prof. Dr. Ion Chiricuță', 400015 Cluj-Napoca, Romania.; Department of Medical Oncology, 'Iuliu Hațieganu' University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania., Lisencu IC; Department of Oncological Surgery and Gynecological Oncology, 'Iuliu Hațieganu' University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.; Department of Surgical Oncology, The Oncology Institute 'Prof. Dr. Ion Chiricuță', 400015 Cluj-Napoca, Romania.

Publikováno v: Biomedicines [Biomedicines] 2022 Mar 25; Vol. 10 (4). Date of Electronic Publication: 2022 Mar 25.

Does Surgical Margin Width Remain a Challenge for Triple-Negative Breast Cancer? A Retrospective Analysis.

Autor: Bonci EA; 11th Department of Oncological Surgery and Gynecological Oncology, 'Iuliu Hațieganu' University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.; Department of Surgical Oncology, 'Prof. Dr. Ion Chiricuță' Institute of Oncology, 400015 Cluj-Napoca, Romania., Țîțu Ș; 11th Department of Oncological Surgery and Gynecological Oncology, 'Iuliu Hațieganu' University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.; Department of Surgical Oncology, 'Prof. Dr. Ion Chiricuță' Institute of Oncology, 400015 Cluj-Napoca, Romania., Petrușan AM; Department of Surgical Oncology, 'Prof. Dr. Ion Chiricuță' Institute of Oncology, 400015 Cluj-Napoca, Romania., Hossu C; Department of Surgical Oncology, 'Prof. Dr. Ion Chiricuță' Institute of Oncology, 400015 Cluj-Napoca, Romania., Gâta VA; 11th Department of Oncological Surgery and Gynecological Oncology, 'Iuliu Hațieganu' University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.; Department of Surgical Oncology, 'Prof. Dr. Ion Chiricuță' Institute of Oncology, 400015 Cluj-Napoca, Romania., Ghomi MT; 11th Department of Oncological Surgery and Gynecological Oncology, 'Iuliu Hațieganu' University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania., Kubelac PM; 11th Department of Oncological Surgery and Gynecological Oncology, 'Iuliu Hațieganu' University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.; Department of Medical Oncology, 'Prof. Dr. Ion Chiricuță' Institute of Oncology, 400015 Cluj-Napoca, Romania., Bonci TI; 11th Department of Oncological Surgery and Gynecological Oncology, 'Iuliu Hațieganu' University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania., Piciu A; 11th Department of Oncological Surgery and Gynecological Oncology, 'Iuliu Hațieganu' University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.; Department of Medical Oncology, 'Prof. Dr. Ion Chiricuță' Institute of Oncology, 400015 Cluj-Napoca, Romania., Cosnarovici M; 11th Department of Oncological Surgery and Gynecological Oncology, 'Iuliu Hațieganu' University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.; Department of Medical Oncology, 'Prof. Dr. Ion Chiricuță' Institute of Oncology, 400015 Cluj-Napoca, Romania., Hîțu L; 11th Department of Oncological Surgery and Gynecological Oncology, 'Iuliu Hațieganu' University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania., Kirsch-Mangu AT; 11th Department of Oncological Surgery and Gynecological Oncology, 'Iuliu Hațieganu' University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.; Department of Radiotherapy, 'Prof. Dr. Ion Chiricuță' Institute of Oncology, 400015 Cluj-Napoca, Romania., Pop DC; 11th Department of Oncological Surgery and Gynecological Oncology, 'Iuliu Hațieganu' University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.; Department of Radiotherapy, 'Prof. Dr. Ion Chiricuță' Institute of Oncology, 400015 Cluj-Napoca, Romania., Lisencu IC; 11th Department of Oncological Surgery and Gynecological Oncology, 'Iuliu Hațieganu' University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.; Department of Surgical Oncology, 'Prof. Dr. Ion Chiricuță' Institute of Oncology, 400015 Cluj-Napoca, Romania., Achimaș-Cadariu P; 11th Department of Oncological Surgery and Gynecological Oncology, 'Iuliu Hațieganu' University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.; Department of Surgical Oncology, 'Prof. Dr. Ion Chiricuță' Institute of Oncology, 400015 Cluj-Napoca, Romania., Piciu D; 11th Department of Oncological Surgery and Gynecological Oncology, 'Iuliu Hațieganu' University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.; Department of Nuclear Medicine, 'Prof. Dr. Ion Chiricuță' Institute of Oncology, 400015 Cluj-Napoca, Romania., Schmidt H; Division of Breast Surgery, Tisch Cancer Institute, Mount Sinai Health System, New York, NY 10029, USA.; Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA., Fetica B; 11th Department of Oncological Surgery and Gynecological Oncology, 'Iuliu Hațieganu' University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania.; Department of Anatomical Pathology, 'Prof. Dr. Ion Chiricuță' Institute of Oncology, 400015 Cluj-Napoca, Romania.

Publikováno v: Medicina (Kaunas, Lithuania) [Medicina (Kaunas)] 2021 Feb 26; Vol. 57 (3). Date of Electronic Publication: 2021 Feb 26.

Malignant phyllodes tumors of the breast associating malignancy of both mesenchymal and epithelial components (invasive or in situ ductal carcinoma).

Autor: Nistor-Ciurba CC; Department of Surgical and Gynecological Oncology, Prof. Dr. Ion Chiricuţă Oncological Institute, Cluj-Napoca, Romania; cosminlisencu@yahoo.com., Şomcutian O, Lisencu IC, Ignat FL, Lazăr GL, Eniu DT

Publikováno v: Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie [Rom J Morphol Embryol] 2020; Vol. 61 (1), pp. 129-135.

Predictors of limph node metastasis in endometrial cancer.

Autor: Ignat FL; 'Ion Chiricuta' Oncological Institute Cluj Napoca ; 'Iuliu Hatieganu' University of Medicine and Pharmacy Cluj Napoca, Oncology Department., Irimie A; 'Ion Chiricuta' Oncological Institute Cluj Napoca ; 'Iuliu Hatieganu' University of Medicine and Pharmacy Cluj Napoca, Oncology Department., Costin N; 'Iuliu Hatieganu' University of Medicine and Pharmacy Cluj Napoca, Oncology Department., Achimas-Cadariu P; 'Ion Chiricuta' Oncological Institute Cluj Napoca ; 'Iuliu Hatieganu' University of Medicine and Pharmacy Cluj Napoca, Oncology Department., Lisencu IC; 'Ion Chiricuta' Oncological Institute Cluj Napoca.

Publikováno v: Clujul medical (1957) [Clujul Med] 2013; Vol. 86 (4), pp. 362-6. Date of Electronic Publication: 2013 Nov 06.